New Jersey’s life sciences sector is poised for continued growth in 2024, following a year in which the industry was a key source of demand for commercial real estate owners.
Another life sciences company is headed to Jersey City from Brooklyn under a newly completed lease with Thor Equities Group, in a deal arranged by brokers with JLL.
Turnkey, high-end life sciences space remains in high demand in New Jersey, creating an opportunity for owners of the state’s few remaining legacy pharmaceutical campuses or those that can find other ways to create new space without building speculatively.
A biotechnology firm is moving from Brooklyn to Jersey City after being awarded a seven-year, $3.5 million tax credit under the Economic Development Authority’s Emerge program.
An institutional lender has provided $47 million in financing to Thor Equities Group for a recently acquired, 330,000-square-foot industrial building in Passaic.
Thor Equities Group has acquired a fully leased, 330,000-square-foot industrial building in Passaic for $52 million, as it touts continued investment in the asset class and the region.
Thor Equities Group has secured predevelopment and construction financing for a plan to build a nearly 151,000-square-foot industrial building in Bogota, according to brokers with JLL.
Thor Equities Group has unveiled plans to build a new 150,000-square-foot industrial building in Bergen County, eyeing further expansion of its platform in northern New Jersey.
Thor Equities Group has added more than 130,000 square feet of industrial space in New Jersey with its acquisition of a two-building complex in Newark.
A company that develops meat from cultured animal cells has become the second tenant to lease space at a newly repurposed, lab-ready building in Jersey City.
